(NASDAQ:CRDF), SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present and host one-on-one meetings at Sidoti's Year-End Virtual Investor Conference, which is taking place from December 10-11, 2025. […]
Montara's BrainOnly platform is designed to prevent peripheral side effects and concentrate neurological drugs' activity in the brain via two-drug combination therapies, comprising its non-brain-penetrant “universal” peripheral blocker development candidate, MT1110, and a brain-penetrant target-specific drug Montara will enter the clinic in H2 2026 to study an MT1110-everolimus combination, called MTX-E1, for the treatment of
(NasdaqGM:KYMR), KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin and blood, respectively, demonstrating strong translation from healthy volunteers to atopic dermatitis (AD) patients KT-621 achieved strong reductions in disease-relevant Type 2 biomarkers in blood, including TARC (median reduction
(NasdaqGM:OBIO),(NYSE:MDT), Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization of AVIM Therapy for treatment of uncontrolled hypertension in patients indicated for a pacemaker NEW HOPE, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation
(TSX:PYR),(OTC US:PYRGF),(Other OTC:PYRGF),(Frankfurt:8PY1), MONTREAL, Dec. 08, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today the recent signing of a half-tonne contract with a Global Aerospace Leader for the supply
(NASDAQ:MRCY), ANDOVER, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a global technology company that delivers mission-critical processing to the edge, will participate in this week's Association of Old Crows (AOC) International Symposium and Convention, showcasing the company's expanding portfolio of electronic warfare (EW) capabilities and sharing key insights during
(NASDAQ:GOGO), SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Farcast, a San Francisco-based startup building advanced satellite user terminals, announces that it has received strategic equity investment from Gogo (Nasdaq: GOGO), a leading in-flight communications provider for business, military, and government aviation, to evolve a new class of aviation user terminals for Gogo customers. The
(Other OTC:OTCM),(OTC US:OTCM),(Other OTC:BMNM), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bimini Capital Management, Inc. (OTCQX: BMNM), an asset manager that speacilizes in residential mortgage-related securities, has qualified to trade on the OTCQX(R) Best Market.
AUSTIN, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — Vetty, the one-stop shop hiring acceleration platform, announced today that it was recently included in Nucleus Research's Hot Companies to Watch in 2026 report. Vetty was selected for driving significant efficiency gains while helping employers maintain compliance. According to Nucleus Research, Vetty was one of only eleven
(NasdaqGM:IRIX), MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a newly published study in Translational Vision Science & Technology (TVST) examining the thermal dynamics of transscleral